Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis

被引:3
作者
Black, Kristin Ashley [1 ,2 ]
Bowden, Sylvie [3 ]
Chu, Pamela [2 ]
McClurg, Caitlin [4 ]
Pin, Sophia [5 ]
Metcalfe, Amy [3 ,6 ]
机构
[1] Univ Calgary, Div Gynecol Oncol, Calgary, AB T2N 4N2, Canada
[2] Univ Calgary, Div Gynecol Oncol, Calgary, AB, Canada
[3] Univ Calgary, Dept Obstet & Gynecol, Calgary, AB, Canada
[4] Univ Calgary, Lib & Cultural Resources, Calgary, AB, Canada
[5] Univ Alberta, Div Gynecol Oncol, Edmonton, AB, Canada
[6] Univ Calgary, Community Hlth Sci, Calgary, AB, Canada
关键词
Venous Thromboembolism; Carcinoma; Ovarian Epithelial; Gynecology; Ovarian Cancer; Preoperative Care; PRIMARY SURGERY; HIGH-RISK; THROMBOPROPHYLAXIS; DALTEPARIN; VALIDATION; SOCIETY; IMPACT; TIME;
D O I
10.1136/ijgc-2023-005166
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Venous thromboembolism is associated with significant patient morbidity, mortality, and can lead to delays in treatment for patients with cancer. The objectives of this study were to identify the incidence of venous thromboembolism in patients with advanced ovarian cancer receiving neoadjuvant chemotherapy, and identify risk factors for venous thromboembolism.Methods A systematic literature search of biomedical databases, including Ovid Medline, Web of Science, Scopus, CINAHL, and Embase was performed on December 6, 2022 and updated on December 21, 2023 for peer reviewed articles. Studies were included if they were cohort studies or randomized controlled trials that evaluated the incidence of venous thromboembolism for patients with ovarian cancer receiving neoadjuvant chemotherapy. Risk of bias assessment was performed using the Newcastle Ottawa Scale for cohort studies and the Cochrane risk of bias tool for randomized controlled trials. Random effects meta-analysis was used to pool results across studies.Results A total of 2636 studies were screened, and 11 were included in the review. Ten were retrospective cohort studies, and one was a randomized controlled trial. The incidence of venous thromboembolism in the included studies ranged from 0% to 18.9%. The pooled incidence rate of venous thromboembolism was 10% (95% confidence interval (CI) 7% to 13%). This remained significant when restricted to only studies with a low risk of bias (pooled incidence of 11%, 95% CI 9% to 14%). Body mass index of >= 30 kg/m2 was a significant risk factor for venous thromboembolism with a pooled odds ratio of 1.76 (95% CI 1.13 to 2.76)Conclusions The results from this study demonstrated a 10% incidence of venous thromboembolism for patients with advanced ovarian cancer receiving neoadjuvant chemotherapy. This suggests that there may be a role for universal thromboprophylaxis in this population.Trial registration PROSPERO CRD42022339602.
引用
收藏
页码:855 / 862
页数:8
相关论文
共 50 条
  • [21] Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis
    Khan, Umair T.
    Walker, Alex J.
    Baig, Sadaf
    Card, Tim R.
    Kirwan, Cliona C.
    Grainge, Matthew J.
    BMC CANCER, 2017, 17
  • [22] Multiple sclerosis and the incidence of venous thromboembolism: a systematic review and meta-analysis
    Ghoshouni, Hamed
    Shafaei, Behnam
    Farzan, Mahour
    Hashemi, Seyedeh Melika
    Afshari-Safavi, Alireza
    Ghaffary, Elham Moases
    Mohammadzamani, Mahtab
    Shaygannejad, Vahid
    Shamloo, Alireza Sepehri
    Mirmosayyeb, Omid
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (03) : 463 - 473
  • [23] Incidence of maternal venous thromboembolism in China: A systematic review and meta-analysis
    Luo, Xingrong
    Shan, Dan
    Zhang, Lin
    Wu, Yuxia
    Li, Tao
    Ren, Yu
    Hu, Yayi
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 163 (01) : 75 - 88
  • [24] Multiple sclerosis and the incidence of venous thromboembolism: a systematic review and meta-analysis
    Hamed Ghoshouni
    Behnam Shafaei
    Mahour Farzan
    Seyedeh Melika Hashemi
    Alireza Afshari-Safavi
    Elham Moases Ghaffary
    Mahtab Mohammadzamani
    Vahid Shaygannejad
    Alireza Sepehri Shamloo
    Omid Mirmosayyeb
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 463 - 473
  • [25] Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature review
    Moufarrij, Sara
    Sassine, Dib
    Basaran, Derman
    Jewell, Elizabeth L.
    GYNECOLOGIC ONCOLOGY, 2023, 170 : 167 - 171
  • [26] Prognostic value of venous thromboembolism in patients with advanced pancreatic cancer: a systematic review and meta-analysis
    Su, Kaifeng
    Duan, Ruifeng
    Wu, Yang
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Prevalence and clinical characteristics of venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis
    Xu, Ying
    Wu, Tong
    Ren, Xue
    Liu, Jing
    Zhang, Haibo
    Yang, Defu
    Yan, Ying
    Lv, Dongyang
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [28] Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis
    Yan, Ann-Rong
    Samarawickrema, Indira
    Naunton, Mark
    Peterson, Gregory M.
    Yip, Desmond
    Newman, Phillip
    Mortazavi, Reza
    THROMBOSIS RESEARCH, 2024, 234 : 120 - 133
  • [29] Incidence of Venous Thromboembolism in Asian Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Song, Joo Hye
    Shim, Sung Ryul
    Kim, Dae Sung
    Koo, Hoon Sup
    Huh, Kyu Chan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, : 774 - 782
  • [30] Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis
    Meng, Kaikai
    Hu, Xiaolan
    Peng, Xiaoxia
    Zhang, Zhenyu
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (03) : 245 - 253